Suchergebnisse - "Bai, Xueli"

PubPharm (274)

61

Multiscale unsupervised domain adaptation for automatic pancreas segmentation in CT volumes using adversarial learning

enthalten in: Medical physics | 2022

von Zhu, Y. | Hu, P. | Li, X. | +4

62

Analysis of the predictors of hypertrophic scarring pain and neuropathic pain after burn

enthalten in: Burns : journal of the International Society for Burn Injuries | 2022

von Shu, F. | Liu, H. | Lou, X. | +8

63

O-GlcNAcylation : an important post-translational modification and a potential therapeutic target for cancer therapy

enthalten in: Molecular medicine (Cambridge, Mass.) | 2022

von Lu, Q. | Zhang, X. | Liang, T. | +1

64

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

enthalten in: Molecular medicine | 2022

von Lu, Q. | Zhang, X. | Liang, T. | +1

65

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

enthalten in: Molecular medicine | 2022

von Lu, Q. | Zhang, X. | Liang, T. | +1

66

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy

enthalten in: Molecular medicine | 2022

von Lu, Q. | Zhang, X. | Liang, T. | +1

67

COMPOSITION FOR TREATING PANCREATIC CANCER AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von LIANG TINGBO | BAI XUELI | SHEN YINAN | +8

68

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer : a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

69

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10

70

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

enthalten in: BMC cancer | 2022

von Ma, T. | Bai, X. | Wei, Q. | +10